论文部分内容阅读
目的探讨早中期食管癌患者采用胸腔镜辅助小切口食管癌根治术对术后并发症、术后恢复的影响。方法 60例早中期食管癌患者,随机分为观察组和对照组,各30例。观察组患者采取胸腔镜辅助小切口手术,对照组患者采取传统开腹手术。比较两组临床治疗效果。结果对照组手术时间为(153.02±40.62)min,观察组手术时间为(151.77±32.85)min,比较差异无统计学意义(P>0.05);观察组术中出血量、术后引流量、住院时间、下床活动时间分别为(198.65±72.88)ml、(178.15±50.73)ml、(5.62±1.48)d、(4.89±1.96)d,均优于对照组的(296.58±139.54)ml、(251.21±28.54)ml、(9.89±2.01)d、(8.98±2.45)d,差异均有统计学意义(P<0.05);对照组并发症发生率为33.33%高于观察组的10.00%,差异具有统计学意义(χ2=4.812,P<0.05)。结论胸腔镜辅助小切口食管癌根治术治疗早中期食管癌患者疗效显著,可降低患者术后并发症的发生率,有利于患者早期恢复,值得在临床上推广。
Objective To investigate the effect of thoracoscopic assisted small incision esophagectomy on the postoperative complications and postoperative recovery in early and mid esophageal cancer patients. Methods Sixty patients with early and mid stage esophageal cancer were randomly divided into observation group and control group, with 30 cases in each group. Patients in the observation group underwent thoracoscopic assisted small incision surgery and patients in the control group underwent traditional laparotomy. Compare the clinical treatment effect of two groups. Results The operation time of the control group was (153.02 ± 40.62) min and the operation time of the observation group was (151.77 ± 32.85) min, with no significant difference (P> 0.05). The intraoperative blood loss, postoperative drainage, Time and ambulation time were (198.65 ± 72.88) ml, (178.15 ± 50.73) ml, (5.62 ± 1.48) d and (4.89 ± 1.96) d respectively, both higher than that of the control group (296.58 ± 139.54) ml, 251.21 ± 28.54) ml, (9.89 ± 2.01) d and (8.98 ± 2.45) d respectively, the difference was statistically significant (P <0.05). The incidence of complications in the control group was 33.33%, which was higher than that in the observation group There was statistical significance (χ2 = 4.812, P <0.05). Conclusions Thoracoscopic assisted small incision esophagectomy for the treatment of early and middle esophageal cancer patients with significant effect, can reduce the incidence of postoperative complications, is conducive to early recovery of patients, it is worth in the clinical promotion.